Canada Mammography Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Canada Mammography Market Trends and Insights

Rapid Replacement of Aging Analog Units

Hospitals that delayed digital conversions are now confronting rising service withdrawals from computed radiography hardware, forcing emergency upgrades at premium prices.^{[1]Institut national de santé publique du Québec, “Contrôle de la qualité des installations de mammographie,” inspq.qc.ca} Quebec eliminated its last CR system in 2023, setting a precedent for other provinces to accelerate retirements. The direct-radiography shift reduces acquisition time to 5–7 minutes per exam, boosting daily throughput by 20–25%. Vendors sweeten trade-in allowances up to 30% of the list price to win multi-unit tenders, thereby reinforcing incumbent market positions. These dynamics keep the Canada mammography market on a steady modernization path.

Provincial Moves to Lower Screening Start-Age to 40 Years

Ontario, Manitoba, Saskatchewan, Newfoundland and Labrador, British Columbia, and Nova Scotia now invite average-risk women from age 40, collectively adding an estimated 1.2 million new participants.^{[2]Government of Canada, “Breast Cancer Screening in Average-Risk Women,” canada.ca} Usage at pre-existing centers in Ontario jumped to 92% before the policy shift, so overflow studies are migrating to hospitals and private clinics. Mobile strategies in Manitoba and Saskatchewan favor geographic equity over brick-and-mortar expansions. The resulting capacity squeeze gives AI-triage tools a clear value proposition. Growth pressures, therefore, concentrate demand in the Canada mammography market’s highest-throughput segments.

Federal AI-in-Health-Care Program Funding

More than CAD 50 million in 2024-2025 grants earmark about 18% for diagnostic imaging AI.^[3] BC Cancer’s CAD 1.5 million mammography study uses Health Canada–approved Genius AI Detection to cut false negatives in dense-breast populations. Provincial RFPs now stipulate algorithm sensitivity benchmarks, turning embedded AI from an optional add-on into a mandatory spec. Open-source work at the Vector Institute aims to limit bias in Indigenous and immigrant cohorts. While only about 30 radiologists hold formal AI credentials, the funding pipeline signals lasting momentum in the Canada mammography market.

Public Bulk-Procurement Frameworks

Quebec’s CAD 6.8–9.2 million dossier 6768 aggregates 158 installations, yielding double-digit price breaks and uniform 48-hour repair terms. Alberta aligned a CAD 175 million Siemens commitment with its broader oncology build-out, capitalizing on shared maintenance teams to trim lifecycle costs by up to 15%. Grouped contracts increasingly require 3D-readiness, compelling vendors to preload tomosynthesis even where reimbursement remains uncertain. Bulk deals thus accelerate specification creep and reinforce service-centric revenue models across the Canada mammography market.

Uneven Provincial Reimbursement for DBT and CEM Modalities

Ontario still lacks a dedicated tomosynthesis fee code, burdening hospitals with an incremental CAD 44 per exam and dampening uptake despite 2.2-point recall-rate gains. Quebec reimburses at flat bilateral rates, while BC’s cost study endorsed DBT, but no schedule change followed. Private clinics charge CAD 150–300 for uncovered 3D exams, cementing a two-tier system. Until fee structures align, reimbursement drag will cap premium-platform penetration in the Canada mammography market.

Shortage of CCPM-Certified Mammography Physicists

Roughly 45 physicists are responsible for accreditation nationwide, resulting in 3- to 6-month waitlists for new-unit certification. Quebec recorded seven temporary service suspensions in 2024 due to inspectors being unavailable. Retirement-driven attrition exceeds new graduates, and private-clinic wage premiums worsen public-sector gaps. Accreditation delays, therefore, slow capital deployment and temper growth expectations for the Canadian mammography market.

*Our updated forecasts treat driver/restraint impacts as directional, not additive. The revised impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Technology: AI Platforms Extend Digital Leadership

Full-Field Digital Mammography owned 61.83% of the Canada mammography market share in 2025, benefiting from reimbursement certainty and PACS compatibility. AI-assisted 3D systems are projected to log a 9.78% CAGR through 2031, lifted by Health Canada's 2024 clearance of Genius AI Detection and a 15–20% drop in radiologist reading time. Digital Breast Tomosynthesis occupies a clinical sweet-spot but remains fee-code-constrained in several provinces.

Hospital buyers in centralized provinces have begun specifying 3D-readiness as the default, whereas in decentralized jurisdictions, units are still procured as cost-optimized 2D units, with upgrades planned later. Saskatchewan’s mobile units illustrate a throughput-first mindset, prioritizing direct radiography and satellite transfer over complex 3D stacks. As a result, the Canada mammography market size for AI-enabled 3D equipment will accelerate once fee schedules catch up, but near-term volume remains anchored in 2D replacements.

Note: Segment shares of all individual segments available upon report purchase

By End User: Private Centers Soak Up Public Backlogs

Hospitals & Surgical Centres retained 55.93% of the Canada mammography market size in 2025 because they host most provincial screening programs and provide same-day diagnostic work-ups. Diagnostic Imaging Centres, however, are poised for an 11.97% CAGR as private operators monetize wait-list spillover and bundle tomosynthesis as a self-pay upgrade.

Urban regions see 8 to 10 new private sites each year, while low-density provinces rely on mobile fleets that cut fixed-site costs by roughly 70%. Private-equity-backed Canada Diagnostic Centres accelerated acquisitions across the Prairies in 2024-2025, confirming investor appetite for diversified outpatient imaging. With screening eligibility widened to age 40, diagnostic volumes keep climbing, ensuring that every end-user segment feeds growth in the Canada mammography market.

Note: Segment shares of all individual segments available upon report purchase

Geography Analysis

Ontario added 800,000 newly eligible women after its April 2024 age change, yet still lacks a DBT code, forcing hospitals to absorb CAD 44 extra per 3D exam and dampening adoption. Quebec’s centralized tender compressed unit prices by up to 20% and mandates tomosynthesis readiness, illustrating how procurement power shapes capital cycles. British Columbia’s dense-breast program exerts additional load on radiologist capacity, boosting AI triage demand.

Saskatchewan and Manitoba emphasize mobile screening to close rural gaps; Saskatchewan’s first two units exceeded utilization forecasts by 28% in their debut month. Atlantic provinces suffer acute physicist shortages, stretching commissioning delays beyond six months. Northern territories rely almost exclusively on visiting units funded through Indigenous Services Canada programs.

Sectra’s province-wide archive now links more than 60 Quebec sites, while OCINet processes 16 million annual images in Ontario, reducing critical-case time-to-read by more than half. Cross-border interoperability remains limited, obliging patients transferred out of province to undergo repeat scans. These provincial contrasts reinforce a multi-speed landscape within the Canadian mammography market.